Skip to main content
. Author manuscript; available in PMC: 2012 Sep 17.
Published in final edited form as: Immunity. 2011 Oct 20;35(4):633–646. doi: 10.1016/j.immuni.2011.08.016

Figure 3. Formation of Distinct LCMV-Specific Effector CD4+ T Cells Subsets.

Figure 3

(A and B) Stg chimeric mice were infected with LCMV and 8 (A) or ~30 (B) days p.i. splenocytes were analyzed by flow cytometry for expression of the indicated proteins. PSGL1hiLy6Chi (red), PSGL1hiLy6Clo (blue), and PSGL1loLy6Clo (green) Stg CD4+ T cells were gated and the average MFI + SD for the various proteins are shown in bar graphs. CD4+ T cells were also stimulated with GP61–80 peptide in vitro and the average frequency of IFN-γ+ and IL-2+ Stg T cells + SD are shown.

Data shown are representative of three independent experiments (n = 3 per group).

(C) Stacked bar graph of Stg CD4 T cells (left) or CD44hi polyclonal CD4+ T cells (right) – SD in each subset after LCMV infection.

(D) Total number of Stg CD4+ T cells + SD of each subset during LCMV infection. Cumulative data from 9–37 mice/time point from more than 20 independent experiments are graphed.

(E) The expression of CD62L and CCR7 on Ly6Chi and Ly6Clo Stg CD4+ T cells at day 60 p.i. is shown in FACS plots. See also Figure S2.